Personalized healthcare is one of the factors augmenting the at-home testing kits market demand. At-home testing kits help in earlier detection of certain disorders such as higher blood pressure, higher bad cholesterol, and even developments such as pregnancy, so that treatment could be started with to avert any further complications. These kits could help in checking the infectious diseases as well.
The companies operating in at-home testing kits market are working toward devising at-home testing kits for critical ailments as well. Such kits will add to the comfort of the patients, as critical tests are still performed within the premises of hospitals and laboratories.
Moreover, increase in the production of existing at-home testing kits is on the anvil, as it would help in combating the pandemic-like situation.
At-home testing kits, also called home use tests, are the kits one can purchase either online or at retail pharmacies or any other brick and mortar stores. These kits facilitate screening or monitoring of some conditions and ailments at the comfort of home.
The most common at-home tests include pregnancy tests, glucose (blood sugar) tests, fecal occult blood test (for colon cancer), tests checking for signs of hepatitis, Covid-19, and HIV, and genetic tests that would show if one is at a risk of some diseases.
Technological advancements, especially with diagnostics and biosensors, are resulting in the development of user-friendly and precise testing kits.
However, stern regulatory requirements pertaining to approval of the at-home testing kits are likely to pose a challenge to manufacturers. Besides, certain complex diagnostic tests may not be suitable for at-home use, thereby limiting scope of these kits.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
The post-pandemic era has raised health consciousness amongst the individuals. Various companies have come forward to conduct research in this regard.
For instance, in February 2023, Abingdon Health plc inked a distribution agreement with Salignostics in order to extend the sales of the latter’s saliva-based pregnancy test kits all over Ireland. In May 2021, Zoe raised US$ 20 Mn for at-home testing kits.
Rise in geriatric population and increase in incidence of chronic diseases are the other factors contributing toward at-home testing kits market growth, apart from those staying in remote areas.
As per the United Nations, the number of individuals aged 65 and above are expected to increase to 1.6 billion in 2050 from 761 billion in 2021. Furthermore, the WHO states that noncommunicable diseases (NCDs) end up claiming 41 million people every year.
Need for timely intervention regarding chronic ailments and reaching out to the ones residing in far-flung areas and aged ones is thus fostering at-home testing kits market opportunities.
Initially, nasal swabs were analyzed by polymerase chain reaction (PCR) in the countries that are equipped with essential laboratory infrastructure People had to wait for longer duration to obtain results of the tests.
However, the scenario changed during as well as post-pandemic era as healthcare landscapes continued to evolve. At present, people opt for at-home diagnostic tests enabled by various technological advancements and driven by consumer expectations.
At-home testing kits can be advantageous for the ones residing in remote areas or those facing issues with mobility. These self-testing kits help in saving on travel time and provide healthcare services to these individuals at their discretion.
At-home testing kits play a vital role regarding preventive healthcare. Self-monitoring at regular intervals can result in early detection of the potential health ailments, thereby facilitating timely or before time medical intervention.
Rise in awareness regarding the benefits of self-testing kits is thus shaping the at-home testing kits market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest at-home testing kits market analysis, North America dominated the self-testing kits landscape in 2023 and the situation is likely to persist during the forecast period. This is attributed to growing prevalence of chronic ailments that diagnosis and treatment at the earliest.
In October 2023, PHASE Scientific Americas introduced INDICAID Health, a virtual platform apprising about its at-home health tests and digital health experiences. The users, after getting test results, can get the needed guidance/advice regarding treatment through this platform.
Certain at-home testing kits facilitate multiple testing, thereby letting a single kit to assess multiple health parameters on simultaneous grounds. This, in turn, improves efficiency of testing and provides a more comprehendible health profile.
The key players in the at-home testing kits industry are involved in launching new products followed by rapid approvals to leave a stronger footprint. For instance, in May 2022, empowerDx announced that it had launched an at-home celiac disease genetic risk test kit that performs molecular testing.
Abbott Laboratories, F. Hoffmann-La Roche AG, Dräger Global, Ascensia Diabetes Care Holdings AG, ARKRAY USA, Inc., Piramal Enterprises, Mankind Pharma, OraSure Technologies, Sterilab Services, Clearblue, Chembio Diagnostics Systems, Inc., and Others are some of the key players covered in the at-home testing kits market report.
These players have been highlighted based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 7.3 Bn |
| Market Forecast (Value) in 2034 | US$ 12.3 Bn |
| Growth Rate (CAGR) | 5.9% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 7.3 Bn in 2023
It is projected to advance at a CAGR of 5.9% from 2024 to 2034
Growing emphasis on personalized healthcare and increase in preference for rapid and convenient diagnostic kits
Molecular diagnostics accounted for the largest share in 2023
North America was the dominant region in 2023
Abbott Laboratories, F. Hoffmann-La Roche AG, Dräger Global, Ascensia Diabetes Care Holdings AG, ARKRAY USA, Inc., Piramal Enterprises, Mankind Pharma, OraSure Technologies, Sterilab Services, Clearblue, Chembio Diagnostics Systems, Inc., and Others
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: At-home Testing Kits Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. At-home Testing Kits Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. At-home Testing Kits Market Analysis and Forecast, by Type of Test
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type of Test, 2020-2034
6.3.1. DNA Testing Kits
6.3.2. Pregnancy Testing Kits
6.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)
6.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)
6.3.5. Allergy Testing Kits
6.3.6. Others
6.4. Market Attractiveness Analysis, by Type of Test
7. At-home Testing Kits Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. Molecular Diagnostics (PCR, qPCR)
7.3.2. Immunoassays (ELISA, lateral flow assays)
7.3.3. Microfluidics
7.3.4. Biosensors
7.3.5. Next-generation Sequencing (NGS)
7.3.6. Other Emerging Technologies
7.4. Market Attractiveness Analysis, by Technology
8. At-home Testing Kits Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020-2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America At-home Testing Kits Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Type of Test, 2020-2034
9.3.1. DNA Testing Kits
9.3.2. Pregnancy Testing Kits
9.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)
9.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)
9.3.5. Allergy Testing Kits
9.3.6. Others
9.4. Market Value Forecast, by Technology, 2020-2034
9.4.1. Molecular Diagnostics (PCR, qPCR)
9.4.2. Immunoassays (ELISA, lateral flow assays)
9.4.3. Microfluidics
9.4.4. Biosensors
9.4.5. Next-generation Sequencing (NGS)
9.4.6. Other Emerging Technologies
9.5. Market Value Forecast, by Country, 2020-2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Type of Test
9.6.2. By Technology
9.6.3. By Country
10. Europe At-home Testing Kits Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type of Test, 2020-2034
10.3.1. DNA Testing Kits
10.3.2. Pregnancy Testing Kits
10.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)
10.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)
10.3.5. Allergy Testing Kits
10.3.6. Others
10.4. Market Value Forecast, by Technology, 2020-2034
10.4.1. Molecular Diagnostics (PCR, qPCR)
10.4.2. Immunoassays (ELISA, lateral flow assays)
10.4.3. Microfluidics
10.4.4. Biosensors
10.4.5. Next-generation Sequencing (NGS)
10.4.6. Other Emerging Technologies
10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Type of Test
10.6.2. By Technology
10.6.3. By Country/Sub-region
11. Asia Pacific At-home Testing Kits Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type of Test, 2020-2034
11.3.1. DNA Testing Kits
11.3.2. Pregnancy Testing Kits
11.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)
11.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)
11.3.5. Allergy Testing Kits
11.3.6. Others
11.4. Market Value Forecast, by Technology, 2020-2034
11.4.1. Molecular Diagnostics (PCR, qPCR)
11.4.2. Immunoassays (ELISA, lateral flow assays)
11.4.3. Microfluidics
11.4.4. Biosensors
11.4.5. Next-generation Sequencing (NGS)
11.4.6. Other Emerging Technologies
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Type of Test
11.6.2. By Technology
11.6.3. By Country/Sub-region
12. Latin America At-home Testing Kits Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type of Test, 2020-2034
12.3.1. DNA Testing Kits
12.3.2. Pregnancy Testing Kits
12.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)
12.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)
12.3.5. Allergy Testing Kits
12.3.6. Others
12.4. Market Value Forecast, by Technology, 2020-2034
12.4.1. Molecular Diagnostics (PCR, qPCR)
12.4.2. Immunoassays (ELISA, lateral flow assays)
12.4.3. Microfluidics
12.4.4. Biosensors
12.4.5. Next-generation Sequencing (NGS)
12.4.6. Other Emerging Technologies
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Type of Test
12.6.2. By Technology
12.6.3. By Country/Sub-region
13. Middle East & Africa At-home Testing Kits Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type of Test, 2020-2034
13.3.1. DNA Testing Kits
13.3.2. Pregnancy Testing Kits
13.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)
13.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)
13.3.5. Allergy Testing Kits
13.3.6. Others
13.4. Market Value Forecast, by Technology, 2020-2034
13.4.1. Molecular Diagnostics (PCR, qPCR)
13.4.2. Immunoassays (ELISA, lateral flow assays)
13.4.3. Microfluidics
13.4.4. Biosensors
13.4.5. Next-generation Sequencing (NGS)
13.4.6. Other Emerging Technologies
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Type of Test
13.6.2. By Technology
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. F. Hoffmann-La Roche AG
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Dräger Global
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Ascensia Diabetes Care Holdings AG
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. ARKRAY USA, Inc.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Piramal Enterprises
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Mankind Pharma
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. OraSure Technologies
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Sterilab Services
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. Clearblue
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
14.3.11. Chembio Diagnostics Systems, Inc.
14.3.11.1. Company Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Financial Overview
14.3.11.5. Strategic Overview
14.3.12. Others
14.3.12.1. Company Overview
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Financial Overview
14.3.12.5. Strategic Overview
List of Tables
Table 01: At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034
Table 02: At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 03: At-home Testing Kits Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 04: North America At-home Testing Kits Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 05: North America At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034
Table 06: North America At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 07: Europe At-home Testing Kits Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 08: Europe At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034
Table 09: Europe At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 10: Asia Pacific At-home Testing Kits Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 11: Asia Pacific At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034
Table 12: Asia Pacific At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 13: Latin America At-home Testing Kits Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Latin America At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034
Table 15: Latin America At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034
Table 16: Middle East & Africa At-home Testing Kits Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Middle East & Africa At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034
Table 18: Middle East & Africa At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034
List of Figures
Figure 01: At-home Testing Kits Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: At-home Testing Kits Market Revenue (US$ Bn), by Type of Test, 2023
Figure 03: At-home Testing Kits Market Value Share, by Type of Test, 2023
Figure 04: At-home Testing Kits Market Revenue (US$ Bn), by Technology, 2023
Figure 05: At-home Testing Kits Market Value Share, by Technology, 2023
Figure 06: At-home Testing Kits Market Value Share, by Region, 2023
Figure 07: At-home Testing Kits Market Value (US$ Bn) Forecast, 2020-2034
Figure 08: At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034
Figure 09: At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034
Figure 10: At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034
Figure 11: At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034
Figure 12: At-home Testing Kits Market Value Share Analysis, by Region, 2023 and 2034
Figure 13: At-home Testing Kits Market Attractiveness Analysis, by Region, 2024-2034
Figure 14: North America At-home Testing Kits Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 15: North America At-home Testing Kits Market Attractiveness Analysis, by Country, 2024-2034
Figure 16: North America At-home Testing Kits Market Value Share Analysis, by Country, 2023 and 2034
Figure 17: North America At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034
Figure 18: North America At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034
Figure 19: North America At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034
Figure 20: North America At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034
Figure 21: Europe At-home Testing Kits Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 22: Europe At-home Testing Kits Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 23: Europe At-home Testing Kits Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 24: Europe At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034
Figure 25: Europe At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034
Figure 26: Europe At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034
Figure 27: Europe At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034
Figure 28: Asia Pacific At-home Testing Kits Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 29: Asia Pacific At-home Testing Kits Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 30: Asia Pacific At-home Testing Kits Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 31: Asia Pacific At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034
Figure 32: Asia Pacific At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034
Figure 33: Asia Pacific At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034
Figure 34: Asia Pacific At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034
Figure 35: Latin America At-home Testing Kits Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 36: Latin America At-home Testing Kits Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 37: Latin America At-home Testing Kits Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 38: Latin America At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034
Figure 39: Latin America At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034
Figure 40: Latin America At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034
Figure 41: Latin America At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034
Figure 42: Middle East & Africa At-home Testing Kits Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 43: Middle East & Africa At-home Testing Kits Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 44: Middle East & Africa At-home Testing Kits Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 45: Middle East & Africa At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034
Figure 46: Middle East & Africa At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034
Figure 47: Middle East & Africa At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034
Figure 48: Middle East & Africa At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
At-home Testing Kits Market
*86 figures and 60 tables includes